BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 23383013)

  • 21. A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies.
    Shames DS; Girard L; Gao B; Sato M; Lewis CM; Shivapurkar N; Jiang A; Perou CM; Kim YH; Pollack JR; Fong KM; Lam CL; Wong M; Shyr Y; Nanda R; Olopade OI; Gerald W; Euhus DM; Shay JW; Gazdar AF; Minna JD
    PLoS Med; 2006 Dec; 3(12):e486. PubMed ID: 17194187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple metastases from cutaneous malignant melanoma patients may display heterogeneous genomic and epigenomic patterns.
    Harbst K; Staaf J; Måsbäck A; Olsson H; Ingvar C; Vallon-Christersson J; Ringnér M; Borg A; Jönsson G
    Melanoma Res; 2010 Oct; 20(5):381-91. PubMed ID: 20848731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
    Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
    World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular Subtype-Specific Expression of MicroRNA-29c in Breast Cancer Is Associated with CpG Dinucleotide Methylation of the Promoter.
    Poli E; Zhang J; Nwachukwu C; Zheng Y; Adedokun B; Olopade OI; Han YJ
    PLoS One; 2015; 10(11):e0142224. PubMed ID: 26539832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multi-platform whole-genome microarray analyses refine the epigenetic signature of breast cancer metastasis with gene expression and copy number.
    Andrews J; Kennette W; Pilon J; Hodgson A; Tuck AB; Chambers AF; Rodenhiser DI
    PLoS One; 2010 Jan; 5(1):e8665. PubMed ID: 20084286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of candidate tumor suppressor genes inactivated by promoter methylation in melanoma.
    Bonazzi VF; Irwin D; Hayward NK
    Genes Chromosomes Cancer; 2009 Jan; 48(1):10-21. PubMed ID: 18803327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrative genome-wide analyses reveal the transcriptional aberrations in Japanese esophageal squamous cell carcinoma.
    Takemoto A; Tanimoto K; Mori S; Inoue J; Fujiwara N; Noda T; Inazawa J
    Cancer Sci; 2021 Oct; 112(10):4377-4392. PubMed ID: 34263978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrative genomics identifies molecular alterations that challenge the linear model of melanoma progression.
    Rose AE; Poliseno L; Wang J; Clark M; Pearlman A; Wang G; Vega Y Saenz de Miera EC; Medicherla R; Christos PJ; Shapiro R; Pavlick A; Darvishian F; Zavadil J; Polsky D; Hernando E; Ostrer H; Osman I
    Cancer Res; 2011 Apr; 71(7):2561-71. PubMed ID: 21343389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrated Genome-Wide Analysis of Gene Expression and DNA Copy Number Variations Highlights Stem Cell-Related Pathways in Small Cell Esophageal Carcinoma.
    Liu D; Xu X; Wen J; Xie L; Zhang J; Shen Y; Jiang G; Chen J; Fan M
    Stem Cells Int; 2018; 2018():3481783. PubMed ID: 30228821
    [No Abstract]   [Full Text] [Related]  

  • 30. Aberrant DNA methylation is associated with aggressive clinicopathological features and poor survival in cutaneous melanoma.
    de Unamuno Bustos B; Murria Estal R; Pérez Simó G; Simarro Farinos J; Pujol Marco C; Navarro Mira M; Alegre de Miquel V; Ballester Sánchez R; Sabater Marco V; Llavador Ros M; Palanca Suela S; Botella Estrada R
    Br J Dermatol; 2018 Aug; 179(2):394-404. PubMed ID: 29278418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genome-wide DNA methylation analysis identifies promoter hypermethylation in canine malignant melanoma.
    Ishizaki T; Yamazaki J; Jelinek J; Aoshima K; Kimura T
    Res Vet Sci; 2020 Oct; 132():521-526. PubMed ID: 32810831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genome-wide profiling of DNA methylation reveals a class of normally methylated CpG island promoters.
    Shen L; Kondo Y; Guo Y; Zhang J; Zhang L; Ahmed S; Shu J; Chen X; Waterland RA; Issa JP
    PLoS Genet; 2007 Oct; 3(10):2023-36. PubMed ID: 17967063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA Methylation Levels of Melanoma Risk Genes Are Associated with Clinical Characteristics of Melanoma Patients.
    de Araújo ÉS; Pramio DT; Kashiwabara AY; Pennacchi PC; Maria-Engler SS; Achatz MI; Campos AH; Duprat JP; Rosenberg C; Carraro DM; Krepischi AC
    Biomed Res Int; 2015; 2015():376423. PubMed ID: 26106605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrated analysis of DNA methylation profiling and gene expression profiling identifies novel markers in lung cancer in Xuanwei, China.
    Wang J; Duan Y; Meng QH; Gong R; Guo C; Zhao Y; Zhang Y
    PLoS One; 2018; 13(10):e0203155. PubMed ID: 30286088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methylation of CpG island promoters in uveal melanoma.
    Moulin AP; Clément G; Bosman FT; Zografos L; Benhattar J
    Br J Ophthalmol; 2008 Feb; 92(2):281-5. PubMed ID: 18211945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of integrative epigenetic and cytogenetic analyses to identify novel tumor-suppressor genes in malignant melanoma.
    Mithani SK; Smith IM; Califano JA
    Melanoma Res; 2011 Aug; 21(4):298-307. PubMed ID: 21606880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Global alterations of DNA methylation in cholangiocarcinoma target the Wnt signaling pathway.
    Goeppert B; Konermann C; Schmidt CR; Bogatyrova O; Geiselhart L; Ernst C; Gu L; Becker N; Zucknick M; Mehrabi A; Hafezi M; Klauschen F; Stenzinger A; Warth A; Breuhahn K; Renner M; Weichert W; Schirmacher P; Plass C; Weichenhan D
    Hepatology; 2014 Feb; 59(2):544-54. PubMed ID: 24002901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrative analysis reveals relationships of genetic and epigenetic alterations in osteosarcoma.
    Kresse SH; Rydbeck H; Skårn M; Namløs HM; Barragan-Polania AH; Cleton-Jansen AM; Serra M; Liestøl K; Hogendoorn PC; Hovig E; Myklebost O; Meza-Zepeda LA
    PLoS One; 2012; 7(11):e48262. PubMed ID: 23144859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genome-wide methylation sequencing of paired primary and metastatic cell lines identifies common DNA methylation changes and a role for EBF3 as a candidate epigenetic driver of melanoma metastasis.
    Chatterjee A; Stockwell PA; Ahn A; Rodger EJ; Leichter AL; Eccles MR
    Oncotarget; 2017 Jan; 8(4):6085-6101. PubMed ID: 28030832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chromosome 7 gain and DNA hypermethylation at the HOXA10 locus are associated with expression of a stem cell related HOX-signature in glioblastoma.
    Kurscheid S; Bady P; Sciuscio D; Samarzija I; Shay T; Vassallo I; Criekinge WV; Daniel RT; van den Bent MJ; Marosi C; Weller M; Mason WP; Domany E; Stupp R; Delorenzi M; Hegi ME
    Genome Biol; 2015 Jan; 16(1):16. PubMed ID: 25622821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.